The association of FGF-23 and Klotho with cognitive impairment and cerebrovascular disease in chronic kidney disease
FGF-23和Klotho与慢性肾脏病认知障碍和脑血管疾病的关系
基本信息
- 批准号:9304203
- 负责人:
- 金额:$ 19.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-01 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAffectAge FactorsAgingAreaBiological AssayBiological MarkersBloodBlood CirculationBlood PressureBlood VesselsBody CompositionBrainBrain DiseasesCardiovascular DiseasesCardiovascular systemCerebrovascular DisordersChronic Kidney FailureClinicalClinical InvestigatorClinical ResearchClinical TrialsCognitionCognitiveCohort StudiesCross-Sectional StudiesDataDementiaDevelopmentDiabetes MellitusDialysis procedureDyslipidemiasEducationElderlyEnsureEpidemiologyEventExhibitsFacultyFibroblast Growth FactorFibroblast Growth Factor ReceptorsFosteringGoalsHealthHeartHemodialysisHigh PrevalenceHippocampus (Brain)HumanHyperglycemiaHypertensionImpaired cognitionIncidenceIntervention TrialKidneyKidney DiseasesKnockout MiceLeft Ventricular HypertrophyLipidsMagnetic Resonance ImagingMaintenanceMediator of activation proteinMemoryMental DepressionMentorsMetabolismMicrovascular DysfunctionMineralsModelingMusNephrologyNervous System TraumaNeuronsOutcomeParticipantPathway interactionsPatientsPopulationPremature aging syndromeProgram DevelopmentRenal functionResearchResearch MethodologyResearch PersonnelResearch Project GrantsResearch ProposalsRisk FactorsRoleSeveritiesStatistical ModelsStrokeSubgroupTrainingTranslational ResearchVascular DiseasesVascular calcificationWorkcardiovascular risk factorcareer developmentcognitive developmentcognitive functioncognitive performancecognitive testingcohortexecutive functionfallsfibroblast growth factor 23high risklongitudinal analysismild cognitive impairmentmodifiable riskmortalitypublic health relevanceracial diversityrandomized trialstatistics
项目摘要
DESCRIPTION (provided by applicant): The long-term objective of this proposal is to foster the scientific development of the candidate to ensure successful transition to an independent clinical investigator. A career development program will focus on didactic training, completion of a research project, and mentoring from a committee with diverse expertise. Didactic training will be of direct relevance to the research proposal including coursework on advanced longitudinal modeling, use of biomarkers, and clinical and translational research methods related to cognition and cognitive impairment. The goal of the research proposal will be to evaluate risk factors for cognitive impairment and cerebrovascular disease in chronic kidney disease (CKD). Cognitive impairment and cerebrovascular disease are highly prevalent in CKD and cannot be fully explained by traditional risk factors such as hypertension, dyslipidemia, and hyperglycemia. Levels of fibroblast growth factor 23 (FGF-23) increase as kidney function declines, while levels of soluble klotho decrease as kidney function declines. High FGF-23 and low klotho have each been associated with an increased risk for cardiovascular events and mortality, and high FGF-23 may cause microvascular disease in the brain while low klotho may result in direct neurological damage. The proposed study will investigate the cross-sectional and longitudinal association of FGF-23 and klotho with cognitive function and cerebrovascular disease using data from two cohort studies (Health Aging and Body Composition Study (Health ABC) and the Cognition and Dialysis Study) and one clinical trial (Systolic Blood Pressure Intervention Trial), spanning all stages of CKD as well those at high risk for CKD. The overall hypothesis is that CKD is characterized by an increase in levels of FGF-23 and a decrease in levels of klotho, and that higher levels of FGF 23 and lower levels of Klotho are associated with the development of cerebrovascular disease and impaired cognitive function. The specific aims are as follows: Aim 1) To determine the cross-sectional and longitudinal association of FGF-23 and klotho with cognitive function and cerebrovascular disease in Health ABC, Aim 2) To determine the cross-sectional and longitudinal association of FGF-23 with cognitive function, stroke, and MRI abnormalities in the CKD subgroup of SPRINT, Aim 3) To assay soluble Klotho in a cohort of maintenance hemodialysis patients and determine the cross- sectional and longitudinal association of FGF-23 and Klotho with cognitive function. All Aims are feasible and have sufficient statistical power. The candidate has assembled a mentoring committee with expertise in clinical research in nephrology, cognition, mineral metabolism, as well as epidemiology and statistics. Dr. Mark Sarnak will serve as the Primary Mentor. He has a long track record of successfully mentoring fellows and junior faculty and has worked in the area of cardiovascular disease, cognition and its associated risk factors for many years. Dr. Joachim Ix will serve as the Co-Mentor. He has extensive expertise in translational and clinical research on mineral metabolism in CKD and has a significant track record of mentoring young investigators.
描述(由申请人提供):本提案的长期目标是促进候选人的科学发展,以确保成功过渡到独立的临床研究者。职业发展计划将侧重于教学培训,完成一个研究项目,并从一个具有不同专业知识的委员会指导。教学培训将与研究提案直接相关,包括高级纵向建模课程,生物标志物的使用,以及与认知和认知障碍相关的临床和转化研究方法。该研究提案的目标是评估慢性肾脏病(CKD)中认知障碍和脑血管疾病的危险因素。认知功能障碍和脑血管疾病在CKD中非常普遍,并且不能完全由传统的风险因素(如高血压、血脂异常和高血糖症)解释。成纤维细胞生长因子23(FGF-23)的水平随着肾功能下降而增加,而可溶性klotho的水平随着肾功能下降而降低。高FGF-23和低klotho均与心血管事件和死亡率的风险增加相关,高FGF-23可能导致脑微血管疾病,而低klotho可能导致直接神经损伤。拟议的研究将调查FGF-23和klotho与认知功能和脑血管疾病的横向和纵向关联,使用来自两项队列研究(健康老化和身体成分研究(健康ABC)和认知和透析研究)和一项临床试验(Syphilis血压干预试验)的数据,涵盖CKD的所有阶段以及CKD的高风险人群。总体假设是CKD的特征在于FGF-23水平的增加和Klotho水平的降低,并且FGF 23水平的升高和Klotho水平的降低与脑血管疾病和认知功能受损的发展相关。具体目标如下:目的1)在健康ABC中确定FGF-23和klotho与认知功能和脑血管疾病的横截面和纵向关联,目的2)在SPRINT的CKD亚组中确定FGF-23与认知功能、中风和MRI异常的横截面和纵向关联,目的3)测定维持性血液透析患者队列中的可溶性Klotho,并确定FGF-23和Klotho与认知功能的横向和纵向关联。所有目标均可行,并具有足够的统计功效。候选人组建了一个指导委员会,具有肾脏学,认知,矿物质代谢以及流行病学和统计学临床研究的专业知识。Mark Sarnak博士将担任主要导师。他在成功指导研究员和初级教师方面有着悠久的历史,并在心血管疾病,认知及其相关风险因素领域工作多年。Joachim IX博士将担任共同导师。他在CKD矿物质代谢的转化和临床研究方面拥有丰富的专业知识,并在指导年轻研究人员方面有着重要的记录。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Alan Drew其他文献
David Alan Drew的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Alan Drew', 18)}}的其他基金
The Relation of Soluble Klotho with Cardiovascular Disease, Chronic Kidney Disease Progression, and Blood Pressure in the Systolic Blood Pressure Intervention Trial
收缩压干预试验中可溶性 Klotho 与心血管疾病、慢性肾病进展和血压的关系
- 批准号:
10180234 - 财政年份:2021
- 资助金额:
$ 19.38万 - 项目类别:
The Relation of Soluble Klotho with Cardiovascular Disease, Chronic Kidney Disease Progression, and Blood Pressure in the Systolic Blood Pressure Intervention Trial
收缩压干预试验中可溶性 Klotho 与心血管疾病、慢性肾病进展和血压的关系
- 批准号:
10618989 - 财政年份:2021
- 资助金额:
$ 19.38万 - 项目类别:
The Relation of Soluble Klotho with Cardiovascular Disease, Chronic Kidney Disease Progression, and Blood Pressure in the Systolic Blood Pressure Intervention Trial
收缩压干预试验中可溶性 Klotho 与心血管疾病、慢性肾病进展和血压的关系
- 批准号:
10451512 - 财政年份:2021
- 资助金额:
$ 19.38万 - 项目类别:
The association of FGF-23 and Klotho with cognitive impairment and cerebrovascular disease in chronic kidney disease
FGF-23和Klotho与慢性肾脏病认知障碍和脑血管疾病的关系
- 批准号:
9923642 - 财政年份:2016
- 资助金额:
$ 19.38万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 19.38万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 19.38万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 19.38万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 19.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists